Zimmer Biomet Gets FDA OK for ROSA Hip System

 Zimmer Biomet Holdings Inc. on Wednesday said the U.S. Food and Drug Administration approved the company's ROSA Hip System for robotically-assisted direct anterior total hip replacement.

The Warsaw, Ind., musculoskeletal healthcare company said the new product adds to a ROSA portfolio that already includes systems for is total and partial knee arthroplasty, and for neurosurgical and spine procedures.

Zimmer said ROSA Hip also enhances its ZBEdge suite of integrated digital and robotic technologies.

https://www.marketscreener.com/quote/stock/ZIMMER-BIOMET-HOLDINGS-I-14996/news/Zimmer-Biomet-Gets-FDA-OK-for-ROSA-Hip-System-36192727/